Deferred Tax Assets, Net of Valuation Allowance of ANI PHARMACEUTICALS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: ANI PHARMACEUTICALS INC quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
ANI PHARMACEUTICALS INC Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $91,609,000, a 18% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

ANI PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$91,609,000	-$19,678,000	-18%	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q4 2024	$111,287,000			31 Dec 2024	10-K	27 Feb 2026	2025	FY
Q4 2018	$100,000			31 Jan 2019	10-Q	06 Nov 2019	2019	Q3
Q4 2011	$0			31 Dec 2011	8-K	28 Jan 2013	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.